coronavirus

billynomates said:
I see that Britain's exit from the UK has enabled quicker vaccine development and approval than if it was still part of the EU.

Rick said:
While a number of Tories have claimed this, it is in fact a shameless, utter lie. This is obvious on two grounds:
1. We're still subject to the EU rules until the end of the year, and yet we have approved it.
2. Hungary have approved the Sputnik vaccine.

SEAL OF APPROVAL Obama, Bush and Clinton volunteer to take coronavirus vaccine live on air to promote jab as 42% say they WON’T take it

BARACK Obama, George W. Bush and Bill Clinton have all volunteered to get the coronavirus vaccine live on air to promote the jab.

The move from the three former US Presidents comes as 42percent of people have said they WON'T take a shot – even after it's been given the green light by the FDA.

Rick said:
2. Hungary have approved the Sputnik vaccine.

luki said:
Do you have a link for this pls?

EDCLARKE said:lol at cum stain Billy

luki said:This is one for the conspiracy lovers. Covid lockdowns being used to destroy small businesses ahead of a Great Reset of the FIAT system. Is the IMF going to launch a digital super currency? 2021 may be the year to buy Crypto Currency.
https://news.bitcoin.com/the-great-financial-reset-imf-managing-director-calls-for-a-new-bretton-woods-moment/

VIII. For a vaccine to work, our immune system needs to be stimulated to produce a
neutralizing antibody, as opposed to a non-neutralizing antibody. A neutralizing antibody is one
that can recognize and bind to some region (‘epitope’) of the virus, and that subsequently
results in the virus either not entering or replicating in your cells. A non-neutralizing antibody is
one that can bind to the virus, but for some reason, the antibody fails to neutralize the infectivity
of the virus. In some viruses, if a person harbors a non-neutralizing antibody to the virus, a
subsequent infection by the virus can cause that person to elicit a more severe reaction to the
virus due to the presence of the non-neutralizing antibody. This is not true for all viruses, only
particular ones. This is called Antibody Dependent Enhancement (ADE), and is a common
problem with Dengue Virus, Ebola Virus, HIV, RSV, and the family of coronaviruses. In fact,
this problem of ADE is a major reason why many previous vaccine trials for other
coronaviruses failed. Major safety concerns were observed in animal models. If ADE occurs in
an individual, their response to the virus can be worse than their response if they had never
developed an antibody in the first place. This can cause a hyperinflammatory response, a
cytokine storm, and a generally dysregulation of the immune system that allows the virus to
cause more damage to our lungs and other organs of our body. In addition, new cell types
throughout our body are now susceptible to viral infection due to the additional viral entry
pathway. There are many studies that demonstrate that ADE is a persistent problem with
coronaviruses in general, and in particular, with SARS-related viruses. ADE has proven to be a
serious challenge with coronavirus vaccines, and this is the primary reason many of such
vaccines have failed in early in-vitro or animal trials. For example, rhesus macaques who were
vaccinated with the Spike protein of the SARS-CoV virus demonstrated severe acute lung
injury when challenged with SARS-CoV, while monkeys who were not vaccinated did not.
Similarly, mice who were immunized with one of four different SARS-CoV vaccines showed
histopathological changes in the lungs with eosinophil infiltration after being challenged with SARS-CoV virus.

XI. Several vaccine candidates are expected to induce the formation of humoral antibodies
against spike proteins of SARS-CoV-2. Syncytin-1 (see Gallaher, B., “Response to nCoV2019
Against Backdrop of Endogenous Retroviruses” - http://virological.org/t/response-to-ncov2019-
against-backdrop-of-endogenous-retroviruses/396), which is derived from human endogenous
retroviruses (HERV) and is responsible for the development of a placenta in mammals and
humans and is therefore an essential prerequisite for a successful pregnancy, is also found in
homologous form in the spike proteins of SARS viruses. There is no indication whether
antibodies against spike proteins of SARS viruses would also act like anti-Syncytin-1
antibodies. However, if this were to be the case this would then also prevent the formation of a
placenta which would result in vaccinated women essentially becoming infertile. To my
knowledge, Pfizer/BioNTech has yet to release any samples of written materials provided to
patients, so it is unclear what, if any, information regarding (potential) fertility-specific risks
caused by antibodies is included.